Biodesix to Participate in Upcoming Investor Conferences

Group 1 - Biodesix, Inc. will participate in two upcoming investor conferences: the 22nd Annual Craig-Hallum Institutional Investor Conference on May 28, 2025, and the 45th Annual William Blair Growth Stock Conference on June 4, 2025 [1] - The presentation at the William Blair Growth Stock Conference will be webcast live and available for replay on the company's website [1] Group 2 - Biodesix is a leading diagnostic solutions company focused on improving clinical care and outcomes for patients, particularly in lung disease [2] - The company's diagnostic tests, Nodify Lung® and IQLung™, support clinical decisions to expedite personalized care [2] - Biodesix Development Services provide scientific, technological, and operational capabilities to biopharmaceutical and life sciences institutions for developing diagnostic tests and therapeutics [2]